EP3490560
NIRAPARIB TIL NOTKUNAR Í AÐFERÐ TIL AÐ MEÐHÖNDLA KRABBAMEIN Í BLÖÐRUHÁLSKIRTLI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.7.2017EP published:
22.1.2025EP application number:
17754226.3
EP translation filed:
14.2.2025Grant published:
15.3.2025EPO information:
European Patent Register
Max expiry date:
27.7.2037Expiry date:
27.7.2026Next due date:
31.7.2026
Title in English:
NIRAPARIB FOR USE IN A METHOD OF TREATING PROSTATE CANCERLanguage of the patent:
English
Timeline
Today
28.7.2017EP application
22.1.2025EP Publication
14.2.2025Translation submitted
15.3.2025Registration published
27.7.2026Expires
Owner
Name:
Janssen Pharmaceutica, N.V.Address:
Turnhoutseweg 30, 2340 Beerse, BE
Inventor
Name:
GOTTARDIS, MarcoAddress:
Princeton New Jersey 08540, US
Name:
HAWKINS, RebeccaAddress:
Spring House 19477, PA
Name:
SNYDER, LindaAddress:
Spring House Pennsylvania 19477, US
Name:
YAMADA, Douglas H.Address:
Spring House Pennsylvania 19477, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201662368466 PDate:
29.7.2016Country:
US
Number:
201662369239 PDate:
1.8.2016Country:
US
Classification
Categories:
A61K 31/454, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.7.2025
Expires: 27.7.2026
Payer: Árnason Faktor ehf.